Related Experiment Videos
Single-dose bromocriptine reverses cocaine craving.
Psychiatry Research
|April 1, 1987
Summary
Bromocriptine, a dopamine agonist, significantly reduced cocaine craving in hospitalized addicts. This suggests bromocriptine may be a promising nonaddictive treatment for cocaine dependence and detoxification.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Chronic cocaine use is associated with functional dopamine depletion.
- Cocaine addiction is a significant public health issue with limited pharmacological treatments.
Purpose of the Study:
- To evaluate the efficacy of bromocriptine in reducing cocaine craving.
- To investigate the role of dopamine agonism in treating cocaine addiction.
Main Methods:
- A randomized, double-blind, placebo-controlled study was conducted.
- Thirteen hospitalized cocaine addicts received a single dose of bromocriptine or placebo.
- Craving ratings were assessed to compare treatment effects.
Main Results:
- Bromocriptine significantly reduced self-reported cocaine craving compared to placebo.
- The dopamine agonist demonstrated a clear effect on craving reduction.
Conclusions:
- Bromocriptine shows potential as a novel, nonaddictive pharmacological treatment for cocaine addiction.
- Findings support the hypothesis of dopamine depletion in chronic cocaine users.
- Low-dose bromocriptine may be beneficial for cocaine detoxification.